RecruitingNAINTERVENTIONAL

Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients

This study is checking if special 'smart' weighing scales can help doctors monitor people with certain blood cancers, such as lymphoma and multiple myeloma, while they have chemotherapy treatment. The aim is to see if using these scales at home helps doctors keep track of patients' health from a distance. Around 30 patients will take part and use a 'Body Comp Pro' smart scale for about 7 weeks. They'll weigh themselves once a day, and this information will go straight to their medical team. The system can send alerts if there are unusual changes in things like weight or heart rate, allowing doctors to act quickly. At the end, researchers will ask patients what they thought of the scales and look at how these alerts helped patient care.

At a glance

Status

Recruiting

Phase

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrolment target

Start

04 Sep 2025

Estimated completion

01 May 2026

Lymphoma, Non-Hodgkin Myeloma Multiple

What is this study about?

This research wants to find out if using special 'smart' weighing scales can be a helpful way for doctors to keep an eye on patients with blood cancers like lymphoma and multiple myeloma. These patients are usually having chemotherapy, and monitoring their health closely is very important. The idea is that these scales, which are connected to a monitoring system, can give doctors regular updates on a patient's health from their own home.

The study will involve about 30 patients who will use a specific smart scale called 'Body Comp Pro' for around 7 weeks. Each day, they'll step on the scale, and the information like their weight will be sent automatically to their medical team. If the scale detects any unusual changes in a patient's health, such as a sudden weight change or an irregular heart rate, it can send an alert to the medical team. This means doctors can be aware of potential problems earlier and step in to help quickly.

At the end of the study, the researchers will talk to the patients to understand how they felt about using the scales and whether they found them helpful. They will also look at how effective the system was in sending alerts and if these alerts led to better care for the patients.

Key takeaways

This study evaluates using 'smart' scales for remote patient monitoring.
It focuses on patients with lymphoma or multiple myeloma undergoing chemotherapy.
Patients use the scale daily for about 7 weeks, sending data to their medical team.
Early alerts could help doctors respond quickly to health changes.
The study also checks patient's opinions on using these scales.

Who may be eligible?

To join this study, you need to be an adult, aged 18 or older. You should have been diagnosed with an aggressive non-Hodgkin's lymphoma or multiple myeloma, and either be about to start chemotherapy, have recently started it (no more than two cycles), or be preparing for a more intensive treatment like an autograft (a type of stem cell transplant) for your myeloma or lymphoma. You also need to be able to use a phone and return home after your initial hospital stay. You must be registered with social security and be able to read and speak French.

There are some reasons why you wouldn't be able to join. For example, if your doctor thinks you have less than 3 months to live, or if you have significant memory problems. You also can't join if you have a physical or mental health issue that would stop you from using the special scales, if you have a pacemaker, or if you're already in another research study that involves a treatment. Pregnant patients, those whose freedom is restricted, or those under certain legal protections (like guardianship) also cannot take part.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Do you have lymphoma or multiple myeloma and are starting or recently started chemotherapy?
Can you be contacted by phone?
Do you have adequate cognitive function to use the device?
Do you have a pacemaker? (If yes, you cannot join).
Are you currently pregnant? (If yes, you cannot join).

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you will be asked to use a special 'smart' weighing scale at home for about 7 weeks. You should try to weigh yourself once every day, ideally at the same time each day. The scale will send your weight and other information directly to your medical team.

You won't need extra hospital visits just for the study, as the monitoring happens remotely from your home. The main activity is consistently using the scale as instructed. There are no new medications given as part of this study; it's purely about using the monitoring device. The total time you'll be involved with the study will be around 7 weeks, though it might be a week shorter or longer.

Potential risks and benefits

A potential benefit of taking part is that your medical team will be closely monitoring your weight and other health indicators daily, which could help them spot any potential issues earlier than usual. This might allow them to adjust your care more quickly if needed. There are very few risks expected from simply using a weighing scale; however, if you have a pacemaker, you cannot participate. You are free to withdraw from the study at any time without giving a reason, and this will not affect your usual medical care.

Locations (1)

Cochin Hospital
Verified postcode
Paris, France· Recruiting

Common questions

What kind of scale will I use?

You'll use a special 'smart' weighing scale called 'Body Comp Pro' from a company called Withings.

How often do I need to use the scale?

You'll need to weigh yourself once a day, ideally at the same time each day.

How long will I be in the study?

You'll be in the study for about 7 weeks, though it could be a little shorter or longer.

Will my doctors see my information?

Yes, your medical team will be able to see your weight and other data through a special online platform.

What happens if there's a problem?

If the scale detects unusual changes in your health, it can send an alert to your medical team so they can act quickly.

How to find out more

Rudy BIRSEN, Dr

rudy.birsen@aphp.fr 01.58.41.42.90 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.